Pituitary adenoma: A clinician's perspective

Endocrine Practice

Volumn 14, Issue 6, 2008, Pages 757-763

  Vance, Mary Lee ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; THYROTROPIN;

ACROMEGALY; ADRENALECTOMY; ARACHNOID CYST; CRANIOPHARYNGIOMA; CUSHING DISEASE; GAMMA KNIFE RADIOSURGERY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; LINEAR ACCELERATOR; PROLACTINOMA; RATHKE CLEFT CYST; REVIEW; TRANSSPHENOIDAL SURGERY; HYPOPHYSIS TUMOR; PATHOLOGY;

HUMANS; PITUITARY NEOPLASMS;

EID: 64749102244     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.6.757     Document Type: Review

References (19)

1. Biller BM, Molitch ME, Vance ML, et al. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab. 1996;81:2338-2343.
2. De Tommasi C, Vance ML, Okonkwo DO, Diallo A, Laws ER Jr. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. J Neurosurg. 2005;103:825-830.
3. Hamilton DK, Vance ML, Boulos PT, Laws ER. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary. 2005;8:53-60.
4. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML. Gamma Knife surgery in Cushing's disease. J Neurosurg. 2007;106:980-987.
5. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab. 2001;86:4072-4077.
6. Mauermann WJ, Sheehan JP, Chernavvsky DR, Laws ER, Steiner L, Vance ML. Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy. J Neurosurg. 2007;106: 988-993.
7. Melmed S, Casanueva F, Cavagnini F, et al. Consensus statement: medical management of acromegaly. Eur J Endocrinol. 2005;153:737-740.
8. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML (Endocrine Society's Clinical Guidelines Subcommittee). Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006;91:1621-1634.
9. Patil CG, Prevedello DM, Lad SP, et al. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab. 2008;93:358-362.
10. Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML. Gamma Knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery. 2006;59:255-266.
11. Vance ML. Hypopituitarism [published correction appears in N Engl J Med. 1994;331:487]. N Engl J Med. 1994;330: 1651-1662.
12. Vance ML. Hypopituitarism-differential diagnosis and treatment. In: Wierman ME, ed. Pituitary Disease: Diagnosis and Treatment. Totowa, NJ: Humana Press, 1997: 33-42.
13. Vance ML. Nonfunctioning pituitary adenoma. Curr Ther Endocrinol Metab. 1994;5:31-33.
14. Vance ML. Nonfunctioning pituitary adenoma. Curr Ther Endocrinol Metab. 1997;6:33-35.
15. Vance ML. Pituitary radiotherapy. Endocrinol Metab Clin North Am. 2005;34:479-487, xi.
16. Vance ML. Resistant prolactinoma. Endocrinologist. 2002;12:357-361.
17. Vance ML, Laws ER Jr. Role of medical therapy in the management of acromegaly. Neurosurgery. 2005;56:877-885.
18. Vance ML, Mauras N. Growth hormone therapy in adults and children. N Engl J Med. 1999;341:1206-1216.
19. Vance ML, Thorner MO. Prolactin: hyperprolactinemic syndromes and management. In: DeGroot L, ed. Endocrinology. Vol 1. 3rd ed. Philadelphia, PA: WB Saunders Co, 1993: 394-405.